![Catherine Isted](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Isted
Financieel Directeur/CFO bij
SANTHERA PHARMACEUTICALS HOLDING AG
Profiel
Catherine Isted currently works at Santhera Pharmaceuticals Holding AG, as Chief Financial Officer from 2025.
Ms. Isted also formerly worked at ReNeuron Group Plc, as Chief Executive Officer & Executive Director from 2022 to 2023, Oxford Biomedica Plc, as Head-Corporate Development & Investor Relations from 2019 to 2021, Nomura Code Securities Ltd., as Sales Associate from 2009 to 2013, Peel Hunt LLP, as Sales Associate from 2015 to 2019, and BenevolentAI SA, as Chief Financial Officer from 2023 to 2024.
Actieve functies van Catherine Isted
| Bedrijven | Functie | Begin |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Financieel Directeur/CFO | 24-02-2025 |
Eerdere bekende functies van Catherine Isted
| Bedrijven | Functie | Einde |
|---|---|---|
| BENEVOLENTAI S.A. | Financieel Directeur/CFO | 03-07-2024 |
| RENEURON GROUP PLC | Algemeen Directeur | 03-01-2023 |
| OXFORD BIOMEDICA PLC | Public Communications Contact | 01-10-2021 |
Peel Hunt LLP
 Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services | Verkoop & Marketing | 01-01-2019 |
Nomura Code Securities Ltd.
 Nomura Code Securities Ltd. Investment ManagersFinance Provides advisory, fundraising, and broking services | Analyst-Equity | 17-07-2009 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
70
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
ReNeuron Group Plc
 ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Nomura Code Securities Ltd.
Nomura Code Securities Ltd. Investment ManagersFinance Provides advisory, fundraising, and broking services | Finance |
Peel Hunt LLP
Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
